Всегда ли пациенткам с раком молочной железы удаляют грудь, рассказал онколог
Всегда ли пациенткам с раком молочной железы удаляют грудь, рассказал онколог ОНТ
Онкология
🎗️Лента новостей
Онкология
Glioblastoma's secret weapon: Silencing the brain's off switch
Researchers at Baylor College of Medicine have discovered a new strategy that glioblastoma, the most common and aggressive form of adult brain cancer, uses to fuel its own growth. Published in the journal Neuron, the study shows in animal models that glioblastoma hijacks the activity of neighboring brain cells…
Онкология
В Воронеже женщине с рецидивом рака удалили поражённое метастазом ребро
В Воронеже женщине с рецидивом рака удалили поражённое метастазом ребро Блокнот Воронеж
🎗️
Онкология
AstraZeneca может начать разработку вакцин от рака — CEO
AstraZeneca может начать разработку вакцин от рака — CEO Investing.com
Онкология
ESMO26: Other skin cancer advances beyond groundbreaking cancer vaccine
ESMO26: Other skin cancer advances beyond groundbreaking cancer vaccine Clinical Trials Arena
Онкология
What Changes in Breast Oncology After ESMO 2026? The Trials, Treatment Shifts, and Unanswered Questions Shaping Clinical Practice
What Changes in Breast Oncology After ESMO 2026? The Trials, Treatment Shifts, and Unanswered Questions Shaping Clinical Practice Oncodaily
Онкология
Maria Hafez: Bridging Gaps in Breast Cancer Care and Access Through Research at ESMO26
Maria Hafez: Bridging Gaps in Breast Cancer Care and Access Through Research at ESMO26 Oncodaily
Онкология
Public knowledge that alcohol causes cancer rebounds
Nearly 6 in 10 Americans (58%) know that regularly consuming alcohol increases the chances of later developing cancer, according to a nationally representative survey in October by the Annenberg Public Policy Center (APPC), a statistically significant increase of five percentage points since February 2026.
🎗️
Онкология
AstraZeneca May Enter Cancer Vaccine Development, CEO Says
AstraZeneca May Enter Cancer Vaccine Development, CEO Says Bloomberg.com
Онкология
Targeted drug significantly delays advanced breast cancer progression but increases toxicity, phase III trial reports
In a global phase 1 trial, trastuzumab rezetecan showed promising signs of fighting ERBB2-low metastatic breast cancer in patients who had already undergone extensive treatment. Also known as HER2-low breast cancer, this subtype is characterized by low levels of HER2, a growth factor protein that can still be targeted…
🎗️
Онкология
World’s first cancer vaccine passes major test
World’s first cancer vaccine passes major test News.com.au
Онкология
Cancer Research UK – Radiation Research Conference 2027
Cancer Research UK – Radiation Research Conference 2027 Oncodaily
Онкология
FDA OKs Talzenna, enzalutamide combo for prostate cancer
The FDA has expanded its approval of talazoparib in combination with enzalutamide to include men with metastatic androgen pathway modulation-naive or -sensitive prostate cancer with homologous recombination repair gene mutations. “This approval represents a critical advancement for patients with newly diagnosed…